EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+13.49%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.37B
AUM Growth
+$167M
(+14%)
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
120
Reduced
185
Closed
27
Top Buys
| 1 |
Microsoft
MSFT
|
$22.3M |
| 2 |
Pinduoduo
PDD
|
$13.5M |
| 3 |
NIO
NIO
|
$13.1M |
| 4 |
Marvell Technology
MRVL
|
$11.4M |
| 5 |
TSMC
TSM
|
$10.4M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$24.2M |
| 2 |
Legend Biotech
LEGN
|
$19.1M |
| 3 |
Trip.com Group
TCOM
|
$15.6M |
| 4 |
Zai Lab
ZLAB
|
$7.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$3.55M |
Sector Composition
| 1 | Consumer Discretionary | 36.1% |
| 2 | Technology | 29.22% |
| 3 | Communication Services | 14% |
| 4 | Healthcare | 8.72% |
| 5 | Real Estate | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Lockheed Martin
LMT
$108B
| $200K | 0.01% |
424
-30
| -7% | -$14.2K |
|
302
Protagonist Therapeutics
PTGX
$3.77B
| $200K | 0.01% |
8,713
-6,769
| -44% | -$155K |
|
|
ICPT
303
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $199K | 0.01% |
14,790
+858
| +6% | +$11.5K |
|
304
Kura Oncology
KURA
$713M
| $191K | 0.01% |
15,588
-1,585
| -9% | -$19.4K |
|
305
Allogene Therapeutics
ALLO
$255M
| $190K | 0.01% |
38,437
-1,208
| -3% | -$5.97K |
|
306
Arcutis Biotherapeutics
ARQT
$2.06B
| $190K | 0.01% |
17,299
+1,419
| +9% | +$15.6K |
|
|
AGEN
307
Agenus
AGEN
$138M
| $188K | 0.01% |
6,310
+1,637
| +35% | +$48.8K |
|
|
CDMO
308
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $188K | 0.01% |
10,037
-6,691
| -40% | -$125K |
|
309
ADMA Biologics
ADMA
$4.03B
| $184K | 0.01% |
55,703
+14,327
| +35% | +$47.3K |
|
310
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $156K | 0.01% |
22,741
-1,846
| -8% | -$12.7K |
|
311
Cogent Biosciences
COGT
$1.82B
| $148K | 0.01% |
13,749
-3,226
| -19% | -$34.7K |
|
312
Day One Biopharmaceuticals
DAWN
$773M
| $145K | 0.01% |
10,867
+103
| +1% | +$1.37K |
|
313
Recursion Pharmaceuticals
RXRX
$2.01B
| $143K | 0.01% |
21,417
-5,694
| -21% | -$38K |
|
314
SiriusXM
SIRI
$8.1B
| $138K | 0.01% |
3,465
-230
| -6% | -$9.16K |
|
315
Lucid Motors
LCID
$5.66B
| $131K | 0.01% |
1,630
+34
| +2% | +$2.73K |
|
|
TSVT
316
DELISTED
2seventy bio
TSVT
| $129K | 0.01% |
+12,601
| New | +$129K |
|
317
Altimmune
ALT
$334M
| $124K | 0.01% |
29,334
-1,952
| -6% | -$8.25K |
|
|
EQRX
318
DELISTED
EQRx, Inc. Common Stock
EQRX
| $121K | 0.01% |
62,580
-1,845
| -3% | -$3.57K |
|
319
Viatris
VTRS
$12.2B
| $114K | 0.01% |
11,886
-408
| -3% | -$3.91K |
|
320
Mersana Therapeutics
MRSN
$34M
| $113K | 0.01% |
1,103
+229
| +26% | +$23.5K |
|
321
Inovio Pharmaceuticals
INO
$148M
| $106K | 0.01% |
10,774
-533
| -5% | -$5.24K |
|
|
ALLK
322
DELISTED
Allakos
ALLK
| $95K | 0.01% |
21,450
+4,701
| +28% | +$20.8K |
|
323
Atara Biotherapeutics
ATRA
$90.7M
| $93K | 0.01% |
1,282
+228
| +22% | +$16.5K |
|
324
Vanda Pharmaceuticals
VNDA
$272M
| $89K | 0.01% |
+13,060
| New | +$89K |
|
325
Alector
ALEC
$305M
| $87K | 0.01% |
14,089
+3,198
| +29% | +$19.7K |
|